Inventor · disambiguated record
F. Stephen Hodi
Also filed as: HODI F S · HODI F STEPHEN
8 granted patents·6 pending applications·39 citations·filing 1999–2020
83Inventor score
Files withDANA FARBER CANCER INST INC10DRANOFF GLENN2DANA-FARBER CAMCER INST INC1DANA-FARBER CANCER INSTITUTE INC1
Top patents by PatentIndex Score
14 records- 0188US9402905B2Therapeutic peptidesDANA FARBER CANCER INST INC·Filed 2013·Granted Aug 2, 2016·14 cites·24 claims
- 0284US10837966B2Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responsesDANA FARBER CANCER INST INC·Filed 2015·Granted Nov 17, 2020·3 cites·17 claims
- 0380US10793633B2Therapeutic peptidesDANA FARBER CANCER INST INC·Filed 2016·Granted Oct 6, 2020·2 cites·3 claims
- 0480US10106611B2Antibodies that bind to MHC class I polypeptide-related sequence ADANA FARBER CANCER INST INC·Filed 2014·Granted Oct 23, 2018·5 cites·36 claims
- 0568US11584788B2Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoformsDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 21, 2023·0 cites·6 claims
- 0666US10279021B2Vaccine compositions and methods for restoring NKG2D pathway function against cancersDANA FARBER CANCER INST INC·Filed 2015·Granted May 7, 2019·1 cites·25 claims
- 0763US7250291B1Tumor antigens and uses thereofDANA FARBER CANCER INST INC·Filed 1999·Granted Jul 31, 2007·14 cites·5 claims
- 0863US2021102948A1Anti-galectin antibody biomarkers predictive of anti-immune checkpoint and anti-angiogenesis responsesDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 0952US10745483B2Therapeutic peptidesDANA-FARBER CANCER INSTITUTE INC·Filed 2014·Granted Aug 18, 2020·0 cites·6 claims
- 1050US2016340407A1Compositions and methods for identification, assessment, prevention, and treatment of melanoma using pd-l1 isoformsDANA-FARBER CAMCER INST INC·Filed 2015·Application pending·0 cites
- 1150US2014037630A1Methods for treating mica-related disordersDANA FARBER CANCER INST INC·Filed 2013·Application pending·0 cites
- 1249US2010111973A1Methods for treating mica-related disordersDRANOFF GLENN·Filed 2007·Application pending·0 cites
- 1341US2008044418A1Tumor Antigens and Uses ThereofDRANOFF GLENN·Filed 2007·Application pending·0 cites
- 1435US2017248603A1Angiopoiten-2 biomarkers predictive of anti-immune checkpoint responseDANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →